How big is the Biosensor Market?

The Biosensor Market size is expected to reach USD 24.12 billion in 2024 and grow at a CAGR of 8.67% to reach USD 36.55 billion by 2029. Read More

What is the current Biosensor Market size?

In 2024, the Biosensor Market size is expected to reach USD 24.12 billion. Read More

Who are the key players in Biosensor Market?

Nix Biosensors Inc., Strados Labs Inc., Bio-Rad Laboratories, Inc., Linxens Inc. and Nova Biomedical Inc. are the major companies operating in the Biosensor Market. Read More

Which is the fastest growing region in Biosensor Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Biosensor Market?

In 2024, the North America accounts for the largest market share in Biosensor Market. Read More

What years does this Biosensor Market cover, and what was the market size in 2023?

In 2023, the Biosensor Market size was estimated at USD 22.03 billion. The report covers the Biosensor Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Biosensor Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Biosensor Market Share

Statistics for the 2023 & 2024 Biosensor market share, created by Mordor Intelligence™ Industry Reports. Biosensor share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Biosensor Industry

The biosensor market is fragmented, with the presence of major players like Nix Biosensors Inc., Strados Labs Inc., Bio-Rad Laboratories Inc., Linxens Inc., Nova Biomedical Inc., Lifeasible Inc., i-Sens Inc., Lifesignals Inc., Universal Biosensors Inc. Dexcom Inc., Aga Matrix Inc., Dynamic Biosensors Inc., SD Biosensors Inc., Pinnacle Technology Inc., Abbott Laboratories Inc. Canatu Inc. Medtronic Inc., and many others. Players in the market are adopting strategies such as partnerships, mergers, innovations, investments, and acquisitions to enhance product offerings and gain sustainable competitive advantage.

May 2024: At the Team Camp in Sierra Nevada, Spain, EF Pro Cycling athletes fully integrated the Nix Hydration Biosensor into their training routines for the entire season. With Nix's advanced biosensor, EF Pro Cycling aims to tailor hydration strategies for its men's and women's teams, optimizing their performance. This partnership underscores EF Pro Cycling's dedication to harnessing advanced technologies for a competitive advantage in the sport.
April 2024: Trinity Biotech PLC and Bayer are entering the increasingly crowded continuous glucose monitoring (CGM) market. The two companies collaborated to develop a CGM biosensor device, which they plan to launch in China and India. This partnership follows Trinity Biotech's acquisition of Waveform Technologies Inc.'s CGM assets earlier this year. With Bayer already established in the diabetes market in India, this collaboration offers Trinity Biotech plc a prime opportunity to promote CGM adoption in this strategically vital and growing market.